1. Home
  2. FLYW vs STOK Comparison

FLYW vs STOK Comparison

Compare FLYW & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flywire Corporation Voting

FLYW

Flywire Corporation Voting

HOLD

Current Price

$16.03

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.11

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLYW
STOK
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
FLYW
STOK
Price
$16.03
$29.11
Analyst Decision
Buy
Strong Buy
Analyst Count
14
10
Target Price
$16.21
$39.20
AVG Volume (30 Days)
2.2M
434.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
450.00
92.73
EPS
0.10
N/A
Revenue
$623,025,000.00
$184,420,000.00
Revenue This Year
$19.68
N/A
Revenue Next Year
$15.25
$77.49
P/E Ratio
$160.60
N/A
Revenue Growth
26.59
404.50
52 Week Low
$9.97
$9.09
52 Week High
$18.05
$40.22

Technical Indicators

Market Signals
Indicator
FLYW
STOK
Relative Strength Index (RSI) 60.70 29.29
Support Level $12.91 $25.21
Resistance Level $18.05 $35.11
Average True Range (ATR) 0.80 1.62
MACD 0.01 -0.41
Stochastic Oscillator 58.32 9.95

Price Performance

Historical Comparison
FLYW
STOK

About FLYW Flywire Corporation Voting

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: